<?xml version="1.0" encoding="utf-8" ?>
<article article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id journal-id-type="publisher-id">TOBIOJ</journal-id>
            <journal-title>The Open Biology Journal</journal-title>
            <abbrev-journal-title abbrev-type="pubmed">Open Bio. J.</abbrev-journal-title>
            <issn pub-type="epub">1874-1967</issn>
            <publisher>
                <publisher-name>Bentham Open</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="publisher-id">TOBIOJ-2-141</article-id>
            <article-id pub-id-type="doi">10.2174/1874196700902010141</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Biology</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration</article-title>
            </title-group>
            <contrib-group>
                <contrib>
                    <name>
                        <surname>A. Herzlich</surname>
                        <given-names>Alexandra</given-names>
                    </name>
                </contrib>
                <contrib>
                    <name>
                        <surname>Ding</surname>
                        <given-names>Xiaoyan</given-names>
                    </name>
                </contrib>
                <contrib>
                    <name>
                        <surname>Shen</surname>
                        <given-names>Defen</given-names>
                    </name>
                </contrib>
                <contrib>
                    <name>
                        <surname>J. Ross</surname>
                        <given-names>Robert</given-names>
                    </name>
                </contrib>
                <contrib>
                    <name>
                        <surname>Tuo</surname>
                        <given-names>Jingsheng</given-names>
                    </name>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Chan</surname>
                        <given-names>Chi-Chao</given-names>
                    </name>
                    <xref ref-type="corresp" rid="cor1">&#x002A;</xref>
                </contrib>
                <aff>Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA</aff>
            </contrib-group>
            <author-notes>
                <corresp id="cor1">
                    <label>&#x002A;</label>Address correspondence to this author at the 10 Center Dr., 10/10N103,
NIH/NEI, Bethesda, MD 20892-1857 USA; Tel: (301) 496-0417; Fax: (301)
402-8664; E-mail: <email xlink:href="chanc@nei.nih.gov">chanc@nei.nih.gov</email></corresp>
            </author-notes>
            <pub-date pub-type="epub">
                <day>25</day>
                <month>11</month>
                <year>2009</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2009</year>
            </pub-date>
            <volume>2</volume>
            <fpage>141</fpage>
            <lpage>148</lpage>
            <history>
                <date date-type="received">
                    <day>14</day>
                    <month>06</month>
                    <year>2009</year>
                </date>
                <date date-type="rev-recd">
                    <day>10</day>
                    <month>09</month>
                    <year>2009</year>
                </date>
                <date date-type="accepted">
                    <day>06</day>
                    <month>10</month>
                    <year>2009</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>&#x00A9; 2009 Chan <italic>et al.</italic></copyright-statement>
                <copyright-year>2009</copyright-year>
                <copyright-holder>Chi-Chao Chan</copyright-holder>
                <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">
                    <p>This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">https://creativecommons.org/licenses/by/4.0/legalcode</uri>). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
                </license>
            </permissions>
            <abstract>
                <p>Peroxisome proliferator-activated receptors (PPARs) play a role in oxidative stress and VEGF regulation,
which are closely related to age-related macular degeneration (AMD). PPAR &#x3B3; expression and its downstream molecules
were examined in fat-1 mice (transgenic mice that convert n-6 to n-3 fatty acids), <italic>Ccl2<sup>-/-</sup></italic>/<italic>Cx3cr1<sup>-/-</sup></italic> mice (an AMD model),
ARPE19 cells (a human retinal pigment epithelial cell line, RPE, a cell type with a critical role in AMD), and human eyes
with and without AMD. PPAR &#x3B1;, &#x3B2;, and &#x3B3;, VEGF and receptors were determined by immunohistochemistry in the mice
models, humans, and ARPE19 cells. Transcripts of PPARs, VEGF, MMP-9 and HO-1 were determined by RQ-PCR.
PPARs were constitutively expressed in normal neuroretina and RPE of humans and mice. PPAR &#x3B3; expression was
increased in fat-1 and <italic>Ccl2<sup>-/-</sup></italic>/<italic>Cx3cr1<sup>-/-</sup></italic> mice. VEGF was decreased in fat-1 mice but increased in <italic>Ccl2<sup>-/-</sup></italic>/<italic>Cx3cr1<sup>-/-</sup></italic> mice.
VEGF receptors were stable. VEGF, MMP9 and HO-1 transcript levels were increased in ARPE19 cells under H<sub>2</sub>O<sub>2</sub> -
induced oxidative stress. Human AMD retinas exhibited higher PPAR &#x3B3;. The findings of increased expression of PPAR &#x3B3;
and its downstream proteins (VEGF, MMP9, and HO-1) in H<sub>2</sub>O<sub>2</sub>-treated ARPE19 cells, <italic>Ccl2<sup>-/-</sup></italic>/<italic>Cx3cr1<sup>-/-</sup></italic> mice, and human
AMD eyes, but decreased VEGF in fat-1 mice, suggest that PPAR &#x3B3; may play a role in AMD.</p>
            </abstract>
        </article-meta>
    </front>
</article>
